Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer (NCT05297890) | CStone Pharmaceuticals | 2022-05-27 |
Track Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.